Medpace Holdings, Inc. (MEDP) Average Profit Margin
The current profit margin for Medpace Holdings, Inc. (MEDP) is N/A as of Wednesday, June 17, 2026, shown against its trailing averages.
Average Profit Margin Chart
MEDP Profit Margin Averages
PROFIT MARGIN CURRENT
N/A
PROFIT MARGIN TTM
18.50%
PROFIT MARGIN 3Y
17.20%
PROFIT MARGIN 5Y
16.74%
PROFIT MARGIN 10Y
12.02%
PROFIT MARGIN 15Y
10.46%
PROFIT MARGIN 20Y
10.46%
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle